ZOGENIX INC's ticker is ZGNX and the CUSIP is 98978L204. A total of 83 filers reported holding ZOGENIX INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $87,000 | -56.3% | 4,460 | -52.6% | 0.00% | – |
Q4 2020 | $199,000 | +255.4% | 9,408 | +199.1% | 0.00% | – |
Q3 2020 | $56,000 | -60.3% | 3,145 | -38.3% | 0.00% | – |
Q2 2020 | $141,000 | +45.4% | 5,097 | +22.6% | 0.00% | – |
Q1 2020 | $97,000 | -67.8% | 4,156 | -28.1% | 0.00% | – |
Q4 2019 | $301,000 | +87.0% | 5,780 | +44.2% | 0.00% | – |
Q3 2019 | $161,000 | -12.0% | 4,008 | +4.8% | 0.00% | – |
Q2 2019 | $183,000 | +1207.1% | 3,825 | +1388.3% | 0.00% | – |
Q1 2019 | $14,000 | -53.3% | 257 | -69.6% | 0.00% | – |
Q4 2018 | $30,000 | -55.9% | 846 | -38.9% | 0.00% | – |
Q3 2018 | $68,000 | +15.3% | 1,384 | +2.9% | 0.00% | – |
Q2 2018 | $59,000 | +34.1% | 1,345 | +22.9% | 0.00% | – |
Q1 2018 | $44,000 | 0.0% | 1,094 | 0.0% | 0.00% | – |
Q4 2017 | $44,000 | -32.3% | 1,094 | -40.7% | 0.00% | – |
Q3 2017 | $65,000 | +140.7% | 1,844 | 0.0% | 0.00% | – |
Q2 2017 | $27,000 | +35.0% | 1,844 | 0.0% | 0.00% | – |
Q1 2017 | $20,000 | -13.0% | 1,844 | 0.0% | 0.00% | – |
Q4 2016 | $23,000 | +9.5% | 1,844 | 0.0% | 0.00% | – |
Q3 2016 | $21,000 | +50.0% | 1,844 | +9.2% | 0.00% | – |
Q2 2016 | $14,000 | -12.5% | 1,688 | 0.0% | 0.00% | – |
Q1 2016 | $16,000 | – | 1,688 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 362,010 | $16,001,000 | 4.79% |
Perceptive Advisors | 3,970,357 | $175,489,000 | 4.60% |
CADIAN CAPITAL MANAGEMENT, LP | 2,051,934 | $90,695,000 | 4.37% |
Broadfin Capital, LLC | 622,380 | $27,509,000 | 4.33% |
RA Capital Management | 1,145,268 | $50,621,000 | 3.29% |
Eversept Partners, LP | 150,845 | $6,667,349 | 3.05% |
SCOPIA CAPITAL MANAGEMENT LP | 3,507,728 | $155,042,000 | 2.71% |
Avoro Capital Advisors LLC | 1,503,313 | $66,446,000 | 2.56% |
Eversept Partners, LP | 123,300 | $5,449,860 | 2.49% |
Broadfin Capital, LLC | 335,000 | $14,807,000 | 2.33% |